MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
329.65%
Quick Ratio
329.65%
Cash Ratio
85.18%
Debt to Asset Ratio
28.92%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Other assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
9,197
8,544
17,470
10,135
Short-term investments
25,323
37,512
40,834
50,456
Accounts receivable and unbilled receivable
189
191
182
254
Prepaid expenses and other current assets
883
1,095
1,642
956
Total current assets
35,592
47,342
60,128
61,801
Property and equipment, net
450
491
578
666
Operating lease right-of-use assets
360
495
629
764
Other assets
927
844
549
549
Total assets
37,329
49,172
61,884
63,780
Accounts payable
3,986
5,480
8,087
2,441
Accrued liabilities
6,354
8,337
7,577
11,539
Operating lease liabilities
457
646
730
726
Total current liabilities
10,797
14,463
16,394
14,706
Operating lease liabilities, net of current portion
0
0
102
284
Total liabilities
10,797
14,463
16,496
14,990
Common stock, 0.0001 par value, 150,000 shares authorized 68,502 and 68,305 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
7
7
7
7
Additional paid-in capital
478,194
477,126
475,361
471,547
Accumulated other comprehensive gain (loss)
-62
-49
50
50
Accumulated deficit
-451,607
-442,375
-430,030
-422,814
Total stockholders equity
26,532
34,709
45,388
48,790
Total liabilities and stockholders equity
37,329
49,172
61,884
63,780
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$25,323K (-57.92%↓ Y/Y)Cash and cashequivalents$9,197K (-14.72%↓ Y/Y)Prepaid expenses andother current assets$883K (-60.10%↓ Y/Y)Accounts receivable andunbilled receivable$189K (-64.07%↓ Y/Y)Total current assets$35,592K (-51.70%↓ Y/Y)Other assets$927K (131.17%↑ Y/Y)Property and equipment,net$450K (-39.43%↓ Y/Y)Operating leaseright-of-use assets$360K (-59.96%↓ Y/Y)Total assets$37,329K (-50.71%↓ Y/Y)Total liabilities andstockholders equity$37,329K (-50.71%↓ Y/Y)Total stockholdersequity$26,532K (-54.73%↓ Y/Y)Total liabilities$10,797K (-36.98%↓ Y/Y)Accumulated deficit-$451,607K (-9.73%↓ Y/Y)Accumulated othercomprehensive gain (loss)-$62K (-464.71%↓ Y/Y)Additional paid-in capital$478,194K (1.71%↑ Y/Y)Total currentliabilities$10,797K (-35.23%↓ Y/Y)Common stock, 0.0001par value, 150,000...$7K (0.00%↑ Y/Y)Accrued liabilities$6,354K (-36.06%↓ Y/Y)Accounts payable$3,986K (-33.68%↓ Y/Y)Operating leaseliabilities$457K (-36.62%↓ Y/Y)

Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology, Inc. (CRDF)